EUVIMED · CrossrefJournal
Modern Rheumatology Journal
ISSN 1996-7012 · IMA Press, LLC
Latest articles
Experience with rituximab in Purtscher retinopathy in a patient with systemic lupus erythematosus (a clinical case)
Current anti-inflammatory therapy for rheumatoid arthritis: efficacy issues (based on EULAR 2025 materials)
Coexistence of psoriatic arthritis and systemic lupus erythematosus in rheumatology practice: challenges of patient management and treatment selection (literature review and clinical case)
Determining the optimal duration of treatment for antineutrophil cytoplasmic antibodyassociated systemic vasculitides. When can therapy be discontinued?
Resolution of the Expert Council “Reproductive health of patients with rheumatic diseases during targeted therapy: from preconception preparation to postpartum follow-up”
Resolution of the Second Forum of Rheumatology Administrators, May 23–24, 2026, supported by the V.A. Nasonova Research Institute of Rheumatology and the League of Eurasian Rheumatologists (LEAR)
Non-interventional multicenter study of the management of patients with non-radiographic axial spondyloarthritis in real-world clinical practice in the Russian Federation (NiSpAR): data from the prospective part
Pharmacoeconomic study of tocilizumab dosing strategies as an intravenous solution in rheumatoid arthritis
Effecacy of a population-based screening program for osteoporosis and high fracture risk in primary healthcare
Evaluation of the utility of hematological indices in monitoring rheumatoid arthritis activity in patients receiving treatment with the direct interleukin 6 inhibitor olokizumab
Development of a prognostic model of work disability in patients with axial spondyloarthritis and its application in real-world clinical practice
Clinical significance of criterial and non-criterial autoantibodies in systemic lupus erythematosus
Prospective study of the effect of a glucosamine hydrochloride and chondroitin sulfate combination on systemic inflammation parameters in patients with knee osteoarthritis (report 2)
Catastrophic antiphospholipid syndrome: diagnosis and treatment
Clinical and neuropsychological characteristics of patients with rheumatoid arthritis depending on pain level associated with the severity of central sensitization. Part 1.
Successful experience with divozilimab therapy for systemic sclerosis
Comparative characteristics of epigenetic regulation in rheumatoid arthritis and osteoarthritis
Takayasu arteritis in patients of the Kyrgyz population with disease onset in adolescence and young adulthood: clinical and laboratory characteristics and prognostic factors for an unfavorable course and outcome
Long-term pharmacotherapy for calcium pyrophosphate deposition disease: results of an observational study
Gastrointestinal tract involvement in systemic sclerosis
Russian-language version of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS)
Russian interdisciplinary consensus on the definitions of “difficult-to-manage” and “difficult-to-treat” psoriatic arthritis/psoriasis and the management of these patients
Assessment of the mortality burden of systemic sclerosis in the Russian Federation: results of a systematic review and meta-regression analysis
Association of serum calprotectin with clinical and laboratory manifestations of systemic lupus erythematosus (preliminary data)
Lupus nephritis in patients from Kyrgyzstan: clinical and laboratory manifestations, disease course variants, and prognostic factors for development
Ocular involvement in antineutrophil cytoplasmic antibody-associated vasculitis
Approaches to therapy of the metabolic phenotype of osteoarthritis: efficacy of a combination of glucosamine and chondroitin sulfate supplemented with undenatured type 2 collagen, B vitamins, gingerol, and ascorbic acid
Predictors of achieving remission in rheumatoid arthritis during levilimab therapy in real-world clinical practice
Diagnostic and treatment features of granulomatosis with polyangiitis in children: comparison of two clinical cases
History and current trends in extracorporeal methods of therapy in rheumatology. Part 1. Treatment of systemic lupus erythematosus
EUVIMED